Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies.
The development of medical approaches requires preclinical and clinical trials for assessment of therapeutic efficacy. Such evaluation entails the use of biomarkers, which provide information on the response to the therapeutic intervention. One newly-proposed class of biomarkers is the microRNA (miRNA) molecules. In muscular dystrophies (MD), the dysregulation of miRNAs was initially observed in muscle biopsy and later extended to plasma samples, suggesting that they may be of interest as biomarkers. First, we demonstrated that dystromiRs dysregulation occurs in MD with either preserved or disrupted expression of the dystrophin-associated glycoprotein complex, supporting the utilization of dystromiRs as generic biomarkers in MD. Then, we aimed at evaluation of the capacity of miRNAs as monitoring biomarkers for experimental therapeutic approach in MD. To this end, we took advantage of our previously characterized gene therapy approach in a mouse model for α-sarcoglycanopathy. We identified a dose-response correlation between the expression of miRNAs on both muscle tissue and blood serum and the therapeutic benefit as evaluated by a set of new and classically-used evaluation methods. This study supports the utility of profiling circulating miRNAs for the evaluation of therapeutic outcome in medical approaches for MD.
INSERM, U951, INTEGRARE research unit, Evry, F-91002, France.|Généthon, Evry, F-91002, France.
David
D
Israeli
INSERM, U951, INTEGRARE research unit, Evry, F-91002, France.|Généthon, Evry, F-91002, France.
Jérôme
J
Poupiot
INSERM, U951, INTEGRARE research unit, Evry, F-91002, France.|Généthon, Evry, F-91002, France.
Fatima
F
Amor
INSERM, U951, INTEGRARE research unit, Evry, F-91002, France.|Généthon, Evry, F-91002, France.
Karine
K
Charton
INSERM, U951, INTEGRARE research unit, Evry, F-91002, France.|Généthon, Evry, F-91002, France.
William
W
Lostal
Généthon, Evry, F-91002, France.
Laurence
L
Jeanson-Leh
INSERM, U951, INTEGRARE research unit, Evry, F-91002, France.|Généthon, Evry, F-91002, France.
Isabelle
I
Richard
D000818:Animals; D015415:Biomarkers / Q000097:blood*; D039481:CD11b Antigen / Q000378:metabolism; D000074166:Circulating MicroRNA / Q000097:blood*; D004195:Disease Models, Animal; D049028:Dystrophin-Associated Protein Complex / Q000235:genetics / Q000378:metabolism; D015316:Genetic Therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology; D009136:Muscular Dystrophies / Q000097:blood* / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D049031:Sarcoglycans / Q000235:genetics
D015415:Biomarkers; D039481:CD11b Antigen; D000074166:Circulating MicroRNA; D049028:Dystrophin-Associated Protein Complex; D049031:Sarcoglycans